Joseph Ciaffoni
CIK 1443841 · Chief Executive Officer · last filed 2026-02-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$21.20M
Companies
4
Total Filings
45
Lifetime Open-Market Net
-$16.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INDV | Chief Executive Officer | 135,976 | $38.48 | $5.23M | $0 | 1 | 2026-02-12 |
| COLL | President and CEO | 444,867 | $34.64 | $15.41M | -$14.98M | 33 | 2024-02-14 |
| ESPR | President and CEO | 177,455 | $3.15 | $559.0K | -$1.95M | 10 | 2019-08-13 |
| Endo International plc (ENDP) Delisted | President, U.S. Branded Pharma | 17,452 | $0.29 | $5.1K | $0 | 1 | 2016-08-18 |
Recent Filings · Page 5 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-07-02 | ESPR | Grant (A) | +25,140 | $0 | EDGAR |
| 2018-06-04 | ESPR | Mixed | −21,067 | -$1.41M | EDGAR |
| 2018-01-29 | ESPR | Grant (A) | +25,000 | $0 | EDGAR |
| 2017-06-02 | ESPR | Grant (A) | +84,268 | $0 | EDGAR |
| 2016-08-18 | Endo International plc (ENDP) Delisted | Grant (A) | +52,356 | $0 | EDGAR |
Showing 41–45 of 45
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.